Last reviewed · How we verify
NCT02926118: GLOW
Continuous Glucose Monitoring During Diets That Differ in Glycemic Load
NA trial testing Low glycemic load in Glucose Metabolism Disorders in 23 participants. Completed in 18 October 2017.
13 July 2017
Quick facts
| Lead sponsor | Unilever R&D |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 23 |
| Start date | 27 April 2017 |
| Primary completion | 13 July 2017 |
| Estimated completion | 18 October 2017 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Low glycemic load
- High glycemic load
Conditions studied
- Glucose Metabolism Disorders — all drugs for Glucose Metabolism Disorders →
Sponsor
Unilever R&D — full company profile →
Who can join
Adults 50 to 70, any sex, with Glucose Metabolism Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study test whether a Continuous Glucose Monitor can pickup differences in glucose (in the interstitial fluid) during a dietary intervention using meals with either a high with a low glycemic load.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02926118
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Low glycemic load
Trials testing the same drug.
- NCT06882460 — Diet and Exercise Solutions to Postprandial Hypotension · NA · recruiting
- NCT04459104 — Pain, Nutrition and Glycemic Response in Chronic Low Back Pain and Breast Cancer Survivors · NA · completed
- NCT02129218 — Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer · NA · completed
Other recruiting trials for Glucose Metabolism Disorders
Currently open trials in the same condition.
- NCT06763562 — Food Orders on Blood Glucose and Fuel Use At Rest · NA · recruiting
- NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
- NCT06051318 — Relationship Between Individual Effect of Diet on Postprandial Glycemia and Gut Microbiome Profile in Healthy Subjects · NA · recruiting
- NCT06358716 — Glycaemic Index Determination in Oral Nutrition Supplements · NA · recruiting
- NCT06878781 — Postprandial Metabolome and Metabolic Flexibility · NA · recruiting
Other Unilever R&D trials
Trials by the same sponsor.
- NCT06640244 — The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening · NA · completed
- NCT06413810 — The Effects of a Food Ingredient on Self-reported Stress · NA · completed
- NCT05013801 — A Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate Melasma · NA · completed
- NCT04155658 — Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation · NA · completed
- NCT03953391 — The Effect of Tea Breaks on Cerebrovascular Perfusion During Desk Work · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02926118 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unilever R&D
- Last refreshed: 19 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02926118.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing